Repetitive transcranial magnetic stimulation treatment of major depressive disorder and comorbid chronic pain: response rates and neurophysiologic biomarkers

Major depressive disorder (MDD) and chronic pain are highly comorbid, and pain symptoms are associated with a poorer response to antidepressant medication treatment. It is unclear whether comorbid pain also is associated with a poorer response to treatment with repetitive transcranial magnetic stimu...

Full description

Saved in:

Bibliographic Details
Published in:	Psychological medicine Vol. 53; no. 3; pp. 823 - 832
Main Authors:	Corlier, Juliana, Tadayonnejad, Reza, Wilson, Andrew C, Lee, Jonathan C, Marder, Katharine G, Ginder, Nathaniel D, Wilke, Scott A, Levitt, Jennifer, Krantz, David, Leuchter, Andrew F
Format:	Journal Article
Language:	English
Published:	Cambridge, UK Cambridge University Press 01.02.2023
Subjects:	Adult Aged Antidepressants Between-subjects design Biological markers Biomarkers Chronic pain Chronic Pain - epidemiology Chronic Pain - therapy Clinical outcomes Coherence Comorbidity Cortex Depressive Disorder, Major - epidemiology Depressive Disorder, Major - therapy Depressive personality disorders Drugs EEG Electroencephalography Female Gender Humans Magnetic fields Male Medical treatment Mental depression Middle Aged Original Original Article Pain Patients Prefrontal cortex Prefrontal Cortex - physiopathology Response rates Resting Sensorimotor system Severity Somatosensory cortex Stimuli Symptoms Transcranial Magnetic Stimulation Treatment Outcome peak alpha frequency (PAF) Repetitive transcranial magnetic stimulation (rTMS) phase coherence Major depressive disorder (MDD) Chronic Pain
ISSN:	0033-2917, 1469-8978, 1469-8978
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!